日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Immunogenicity and Safety of a 3-Antigen Hepatitis B Vaccine vs a Single-Antigen Hepatitis B Vaccine: A Phase 3 Randomized Clinical Trial

三抗原乙肝疫苗与单抗原乙肝疫苗的免疫原性和安全性：一项3期随机临床试验

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2021.28652
Vesikari, Timo; Finn, Adam; van Damme, Pierre; Leroux-Roels, Isabel; Leroux-Roels, Geert; Segall, Nathan; Toma, Azhar; Vallieres, Gerald; Aronson, Ronnie; Reich, Dennis; Arora, Samir; Ruane, Peter J; Cone, Clancy L; Manns, Michael; Cosgrove, Catherine; Faust, Saul N; Ramasamy, Maheshi N; Machluf, Nathalie; Spaans, Johanna N; Yassin-Rajkumar, Bebi; Anderson, David; Popovic, Vlad; Diaz-Mitoma, Francisco
免疫/内分泌
发表日期：2021
文献求助 收藏

8. Higher hepatitis B antibody titres induced in all adults vaccinated with a tri-antigenic hepatitis B (HBV) vaccine, compared to a mono-antigenic HBV vaccine: results from two pivotal phase 3 double-blind, randomized studies (PROTECT and CONSTANT)

8. 与单抗原乙肝疫苗相比，接种三抗原乙肝疫苗的所有成年人体内诱导产生的乙肝抗体滴度更高：两项关键性 3 期双盲随机研究（PROTECT 和 CONSTANT）的结果

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines9101072
Bonam, Srinivasa Reddy; Rénia, Laurent; Tadepalli, Ganesh; Bayry, Jagadeesh; Kumar, Halmuthur Mahabalarao Sampath; Langley, Joanne M; Vesikari, Timo; Machluf, Nathalie; Spaans, Johanna; Yassin-Rajkumar, Bebi; Anderson, Dave; Popovic, Vlad; Diaz-Mitoma, Francisco
TEC
发表日期：2020
文献求助 收藏